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We now study the role of ERD AF-2 in these two major bene¿ cial actions 
of E2 thanks to a mouse model deleted for 6 amino acid of the helix 12 and 
thereby de¿ cient in ERD AF-2 (named ERD AF-20). The uterotrophic action 
of E2 was totally absent in AF-20 mice showing the crucial role of ERD 
AF-2 in uterus hyperplasia. The atheroprotective effect of E2 was abrogated 
in ERDAF-20 LDLr-/- mice, demonstrating the absolute requirement of ERD 
AF-2 for this action. By contrast, ERD AF-2 was dispensable for the accelera-
tive action of E2 on endothelial healing.
To conclude, ERD AF-2 is dispensable for the E2 action on reendothelia-
lization which rather involves membrane initiated steroid signal as recently 
demonstrated (Chambliss et al. JCI 2010), but is absolutely required for the 
E2 atheroprotective effect.
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After stroke, subsequent cardio- and cerebrovascular events clearly affect 
outcome. The natural history of asymptomatic coronary artery disease (CAD) 
and the impact of myocardial revascularization remain unclear. The aim of this 
study is to report clinical outcomes after screening for asymptomatic CAD in 
stroke patients at three years.
Methods and results: Among 274 patients in the PRECORIS trial, 50 had 
at least one coronary stenosis ³50% on multislice computed tomography. The 
extent and the severity of CAD was evaluated with coronary angiography 
(n=39). Clinical follow-up was obtained up to three years. Major cardio- and 
cerebrovascular events (MACCE) were prospectively collected.
Median age was 66.2 years. Single-, two- and three-vessel diseases were 
present in 21, 23, and 46% of patients respectively. 
Left anterior descending artery, left circumflex artery and right coro-
nary artery were significantly stenosed in 79, 69, and 67% of patients, res-
pectively. Coronary stenoses were 70% in 85%, 90% in 24% and 11% 
of coronary arteries are totally occluded. The mean SYNTAX score was 
22.3±12.7.
In addition to medical therapy, eleven patients were revascularized. No 
major complication occurred during the ¿ rst month after revascularization.
The overall 3-year rate of myocardial revascularizations was 24%. After 
3 years, 76% of the patients were alive and free of MACCE.
Conclusion: In stroke patients, asymptomatic CAD appeared to be diffuse, 
complex, and severe. Although potentially affected by myocardial revasculari-
zation, the rate of MACCE at 3 years is 24%, indicating a signi¿ cant burden 
of cardio- and cerebrovascular events in these patients. There is currently 
no recommendation to guide myocardial revascularization in such patients. 
However, because natural history of patients after ischemic stroke deserves 
therapeutic improvement, revascularization could be indicated in most severe 
cases and deserves further investigations. 
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Obstructive sleep apnea (OSA) syndrome is a highly prevalent disease, cha-
racterized by repetitive upper airway collapses during sleep resulting in inter-
mittent hypoxia (IH). IH plays a major role in cardiovascular and  metabolic 
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Purpose: Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an 
inÀ ammatory biomarker secreted in the atherosclerotic plaque. We aimed to 
evaluate the association of Lp-PLA2 with the severity of angiographic CAD 
and the extracoronary atherosclerosis. 
Methods: Subjects were recruited from a population scheduled for dia-
gnostic coronary arteriography, 494 patients (69.8% men, 64.2±16.7y. Several 
clinical parameters were obtained from all patients (age, sex, BMI and treat-
ment), coronarography (localization and extent of luminal narrowing for 15 
segments of the major coronary arteries) and carotid ultrasonography (degree 
of stenosis was strati¿ ed into the categories of <50% stenosis (no stenosis), 
50% to 69% stenosis (mild stenosis), >70% stenosis to near occlusion (99%) 
or total occlusion (severe stenosis). Lp-PLA2 was measured in serum with 
a Plac® test turbidimetric immunoassay. Control values were measured from 
61 healthy subjects aged 44.5±17.6 y (25 -59y) without cardiovascular risk 
factors nor cardiac treatment.
Results: In healthy controls, mean Lp-PLA2 was 163±43 Pg/L (men 
166±45 and women159±39, NS). Lp-PLA2 levels were 216±17Pg/L and 
increased signi¿ cantly in patients with CAD as compared to patients without 
CAD (223±54 vs 208±52g/L; p<0.007). Lp-PLA2 levels were signi¿ -
cantly higher in patients with more extensive angiographic CAD [respec-
tively: single=215.2±52g/L (n=24); two=222±53g/L (n=55) and three 
vessels=251.9±53.7g/L (n=140); p<0.0001]. In patients with carotid arte-
ries disease, Lp-PLA2 increased signi¿ cantly with the severity of atheroscle-
rosis. Mean Lp-PLA2 levels were respectively at 218.8±51g/L in the group 
without stenosis (n=108), 224±51g/L in the mild stenosis group (n=101), and 
at 231±46g/L in the severe stenosis group (n=22); p=0.004.
Conclusion: Level of Lp-PLA2 had a sidni¿ cant association with coro-
nary heart disease and also with the extension of extra coronary after adjust-
ment for age and sex.
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Estradiol (E2) regulates estrogen receptor alpha (ERD) target gene trans-
cription through the two independent activation functions (AF)-1 and -2. We 
previously reported that ERD is required, but its AF-1 dispensable, for the E2 
atheroprotective action as well as for its accelerative action on endothelial 
healing (Billon-Gales et al. PNAS 2009).
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complications, however the pathophysiological link remains unclear. Since 
abdominal fat is recognized as an endocrine and paracrine organ with an 
important role in inÀ ammation and atherogenesis, we postulate that the inÀ am-
matory and atherogenic role of IH could be mediated at least in part through 
IH-related changes in visceral adipose tissue (vAT). Dyslipidemic and athe-
rosclerosis-prone apolipoprotein E-de¿ cient mice were exposed to either IH 
(1 min cycle, FiO2 21-5%, 8 h/day) or air (normoxic mice, N) during 6 weeks. 
Three days before exposure, IH and N mice were lipectomized or sham ope-
rated. After exposure, mice were sacri¿ ced and analyzed for atherosclerosis 
development and AT alterations. Some of the animals were assessed for 
insulin sensitivity using the insulin tolerance test. IH aggravated both the dys-
lipidemia and the development of atherosclerosis. IH also induced structural 
and inÀ ammatory remodeling of adipose tissue. Adipocytes size decreased in 
both epididymal and subcutaneous fat pads but inÀ ammatory changes were 
observed in epididymal fat only, and characterized by macrophage in¿ ltra-
tion and increased MCP-1 expression. IH mice also developed insulin resis-
tance. Epididymal lipectomy prevented the dyslipidemic effects of IH and 
attenuated the IH-induced atherogenesis. In contrast, the IH-induced elevation 
in plasmatic glycerol and free fatty acid remained unchanged. In conclusion 
we con¿ rmed the dyslipidemic and pro-atherogenic role of IH. The functional 
meaning of the adipose tissue plasticity needs to be determined, as well as the 
involvement of the other adipose compartments. Our preliminary results bring 
new insight into the pathophysiology of OSA-related atherosclerosis.
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Introduction: Oxidized LDLs (oxLDLs) exhibit a variety of atherogenic 
properties including foam cell formation, inÀ ammatory response, cell proli-
feration at low concentration, and apoptosis at higher concentration. OxLDLs 
may alter the fragile balance between survival and death of vascular cells 
thereby leading to plaque instability and atherothrombosis. In contrast, the 
anti-atherogenic high-density lipoproteins (HDLs) inhibit LDLs oxidation, and 
counteract several adverse biological effects, such as cytotoxicity and inÀ am-
matory response triggered by cytokines and oxLDLs.
Objectives: To more deeply investigate the mechanisms mediating the pro-
tective role of HDLs, we studied whether ER stress and autophagy were impli-
cated in oxLDLs-induced apoptosis and whether HDLs prevented these stress 
processes.
Methods and Results: In human endothelial cells, oxLDLs induce the 
activation of ER stress sensors and subsequent activation of the pro-apop-
totic mediators JNK and CHOP. We report that oxLDLs trigger the conver-
sion LC3-I to the lipidated form, LC3-II and an increase expression of the 
autophagy regulator Beclin-1. The autophagic process is independent of the 
pro-apoptotic arms of ER stress, but Beclin-1 contributes to PS exposure and 
subsequent phagocytosis of oxLDLs- exposed cells. Induction of ER stress, 
autophagy and PS exposure by oxLDLs are prevented by HDLs pretreatment. 
Finally, the cytosolic Ca2+ deregulation triggered by oxLDLs is a common 
signalling pathway that mediates ER stress-induced cell death and autophagy, 
all these events being blocked by HDLs.
Conclusions: OxLDL-induced ER stress is associated to autophagy acti-
vation which is not involved in oxLDL-mediated cell death machinery but 
contributes to phagocytosis of oxLDLs- exposed cells. HDLs by bloc-
king the Ca2+ deregulation, and consequently both ER stress and autophagy, 
may reduce level of ER stress and autophagy markers detected in early and 
advanced atherosclerotic lesions.
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